Mon-20-04-2015, 15:32 PM
They didn't report secondary end point? Shame on them...
Ixekizumab meets it's goals in Phase 3 for psoriatic arthritis.
|
« Next Oldest | Next Newest »
|
Messages In This Thread |
Ixekizumab meets it's goals in Phase 3 for psoriatic arthritis. - by Fred - Mon-20-04-2015, 14:48 PM
RE: Ixekizumab meets it's goals in Phase 3 for psoriatic arthritis. - by mataribot - Mon-20-04-2015, 15:32 PM
RE: Ixekizumab meets it's goals in Phase 3 for psoriatic arthritis. - by jiml - Mon-20-04-2015, 15:34 PM
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
![]() |
Psoriasis to psoriatic arthritis characterised by alterations in T cells | Fred | 1 | 323 |
Wed-17-09-2025, 20:43 PM Last Post: Caroline |
![]() |
Tremfya goes for psoriatic arthritis | Fred | 2 | 773 |
Thu-21-08-2025, 16:19 PM Last Post: Fred |
![]() |
Sotyktu accepted for review in psoriatic arthritis | Fred | 0 | 832 |
Tue-22-07-2025, 11:41 AM Last Post: Fred |
![]() |
Ilumya / Ilumetri phase 3 for psoriatic arthritis | Fred | 0 | 733 |
Tue-22-07-2025, 11:24 AM Last Post: Fred |
![]() |
Spyre SPY072 for psoriatic arthritis phase 1 | Fred | 1 | 1,102 |
Thu-17-07-2025, 20:15 PM Last Post: Caroline |